Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy(LOE Classification)

Authors :: Hughes, R. A.C.
Gorson, K. C.
Cros, D.
Griffin, J.
Pollard, J.
Vallat, J. -M.
Maurer, S. L.
Riester, K.
Davar, G.
Dawson, K.
Sandrock, A.
Source :: Neurology (Ovid); February 2010, Vol. 74 Issue: 8 p651-657, 7p
Publication Year :: 2010
Abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) shares immunologic features with multiple sclerosis (MS). Because IM interferon beta-1a (IM IFN-1a) is an effective and safe treatment for MS, we conducted a dose-ranging efficacy study of IFN-1a in patients with CIDP.

Full Text Access

Tools